Free Trial
NASDAQ:ANAC

Arctos NorthStar Acquisition (ANAC) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$10.19
$10.19
50-Day Range
$9.68
$9.79
52-Week Range
$9.44
$10.20
Volume
705 shs
Average Volume
53,611 shs
Market Capitalization
$402.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ANAC stock logo

About Arctos NorthStar Acquisition Stock (NASDAQ:ANAC)

Arctos NorthStar Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It focuses on sports, media, and entertainment sectors. The company was founded in 2020 and is based in Dallas, Texas.

ANAC Stock News Headlines

Northstar Clean Technologies Inc ROOF
Metal Sky Star Acquisition Corp
The asset beating inflation by 4x
Central Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire investors are buying right along with them. Even Warren Buffett put over $500 million into gold. And with the help of a tax and penalty-free "Trump Loophole, " these investors are investing retirement into gold and other precious metals without having to put up any of their own cash. In our Free Precious Metals Guide, we reveal all the details on how the rich use this loophole to protect and growth their retirement wealth in any economy…and show you how you can use it too.
Northstar California Resort
Arctos Northstar Acquisition Corp
The asset beating inflation by 4x
Central Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire investors are buying right along with them. Even Warren Buffett put over $500 million into gold. And with the help of a tax and penalty-free "Trump Loophole, " these investors are investing retirement into gold and other precious metals without having to put up any of their own cash. In our Free Precious Metals Guide, we reveal all the details on how the rich use this loophole to protect and growth their retirement wealth in any economy…and show you how you can use it too.
ANAC_u Technical Analysis
Arctos Northstar Acquisition Corp (ANAC)
Arctos Northstar Acquisition Corp Unit (ANAC_u)
Arctos NorthStar Acquisition Corp. Cl A
Arctos NorthStar Acquisition Corp. Wt
See More Headlines
Receive ANAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arctos NorthStar Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/10/2016
Today
6/18/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Holding & other investment offices
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ANAC
CUSIP
03242010
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$7.16 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.18 per share
Book Value
($0.63) per share

Miscellaneous

Free Float
N/A
Market Cap
$402.81 million
Optionable
Not Optionable
Beta
N/A
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Key Executives

  • Mr. Theo Epstein (Age 47)
    CEO & Director
  • Mr. John Barney Vedro CPA (Age 45)
    CPA, Chief Financial Officer

ANAC Stock Analysis - Frequently Asked Questions

How were Arctos NorthStar Acquisition's earnings last quarter?

Arctos NorthStar Acquisition Corp. (NASDAQ:ANAC) released its quarterly earnings data on Tuesday, May, 10th. The biopharmaceutical company reported ($0.36) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.35) by $0.01. The biopharmaceutical company had revenue of $17.54 million for the quarter, compared to the consensus estimate of $19.53 million. Arctos NorthStar Acquisition's quarterly revenue was up 14.9% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.30) earnings per share.

What other stocks do shareholders of Arctos NorthStar Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Arctos NorthStar Acquisition investors own include Micron Technology (MU), Portola Pharmaceuticals (PTLA), bluebird bio (BLUE), Netflix (NFLX), BioMarin Pharmaceutical (BMRN), Intercept Pharmaceuticals (ICPT), NXP Semiconductors (NXPI) and ACADIA Pharmaceuticals (ACAD).

This page (NASDAQ:ANAC) was last updated on 6/18/2024 by MarketBeat.com Staff

From Our Partners